Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Cardiomyopathies: full-pipeline trial registry
13 of 18 indexed Cardiomyopathies trials are currently recruiting.
Corpus placement: #953 of 28,707 conditions by registered trial count.
18 US clinical trials · 13 currently recruiting · #953 of 28,707 conditions by registered trial count
Cardiomyopathies: 18 US clinical trials tracked, 13 recruiting.
Cardiomyopathies is the subject of 18 registered US clinical trials on ClinicalTrials.gov, 13 of them currently open to new participants. 2 are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most active sponsor is Mayo Clinic, running 2 of these trials.
Enrollment posture brief
Registry condition cardiomyopathies
OPEN 13 | RECR 72% | LATE 2 | EARLY 3 | RANK #953 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Intrahepatic Cholangiocarcinoma (72% recruiting · 18 trials)
Cardiomyopathies lists 13 open slots (72% of 18 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Cardiomyopathies on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Cardiomyopathies is recruiting above its size-band peers.
13 of 18 indexed trials (72.2%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Cardiomyopathies trials is spread across many organizations.
Mayo Clinic accounts for 2 of 18 trials (11.1%). 15 distinct sponsors appear on at least one study for this condition label.
-
Typical Cardiomyopathies enrolment sits around 270 participants.
Median target enrolment is 270 among the 18 trials that report a genuine target (sentinel values excluded). 5 of those (27.8%) plan for fewer than 100 participants.
-
Cardiomyopathies research leans observational.
7 interventional and 11 observational studies make up this index (38.9% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
18 total, page 1 of 1
Cardiovascular Multimodality Imaging Study
Montefiore Medical Center
NCT06610019
Prospective Observational Study of the ICD in Sudden Cardiac Death Prevention
Johns Hopkins University
NCT00733590
Mayo AVC Registry and Biobank
Mayo Clinic
NCT03049254
Genetic Markers of Cardiovascular Disease in Epilepsy
Mayo Clinic
NCT02824822
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
Eidos Therapeutics, a BridgeBio company
NCT06563895
PPG to Predict Ejection Fraction and Other Echographic Data in the General Population
Tulane University
NCT04843371
Optimizing Beta Blocker Dosage in Women While Using the Wearable Cardioverter Defibrillator
Zoll Medical Corporation
NCT04504188
Pediatric Cardiomyopathy Mutation Analysis
Indiana University
NCT02432092
Evaluating Pulse Oximetry Bias in Children With Darker Skin Pigmentation
Stanford University
NCT05617547
The PIVATAL Study -Study of Ventricular Arrhythmia (VTA) Ablation in Left Ventricular Assist Device (LVAD) Patients
University of Rochester
NCT05034432
Multicenter Trial of ECMO in Children With Severe Cardiac Failure Using the Cardiohelp System
Stanford University
NCT06080074
PKP2-ACM Natural History Study
Rocket Pharmaceuticals
NCT06644742
Phase IA and IB Study of AAVrh.10hFXN Gene Therapy for the Cardiomyopathy of Friedreich's Ataxia
Weill Medical College of Cornell University
NCT05302271
Factors Associated With Response to Cardiac Resynchronization Therapy in Heart Failure Patients With Non-LBBB ECG Pattern
University of Rochester
NCT06977217
Edema and Fibrosis CMR Imaging in Cardiomyopathy
University of Pennsylvania
NCT03534726
Thoratec HeartMate II Left Ventricular Assist System (LVAS) for Destination Therapy
Abbott Medical Devices
NCT00121485
Cardio-pulmonary Rehabilitation and Sleep Quality
MetroHealth Medical Center
NCT04668599
Risk-Guided Cardioprotection With Carvedilol in Breast Cancer Patients Treated With Doxorubicin and/or Trastuzumab
Abramson Cancer Center at Penn Medicine
NCT04023110
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 2 |
| Phase 2 | 1 |
| Phase 3 | 1 |
| Phase 4 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Cardiomyopathies records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Cardiomyopathies trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Cardiomyopathies page
18 registered trials, 13 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 13 Cardiomyopathies trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Mayo Clinic sponsors the most Cardiomyopathies trials on record, review their full trial history before evaluating a specific study. See Mayo Clinic's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Cardiomyopathies condition card totals 18 registered trials; most-linked intervention Cardiopulmonary rehabilitation; top US site state New York. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.